Filing Flows › Harmony Biosciences Holdings (HRMY) › Free cash flow
Harmony Biosciences Holdings (HRMY) free cash flow by quarter
Harmony Biosciences Holdings' free cash flow was $126M in Q4 2025 (fourth quarter 2025), +16% from Q3 2025. Over the last 4 quarters it ranged from $33.9M (Q1 2025) to $126M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $126M | +16% | — |
| Q3 2025 | $109M | +37% | — |
| Q2 2025 | $79.3M | +134% | — |
| Q1 2025 | $33.9M | — | — |
Q4 2025 at a glance
Harmony Biosciences Holdings, Q4 2025: revenue $244M (+21% year over year), operating margin 15.8%, net earnings $22.5M, operating cash flow $126M. The chart follows the revenue to costs, profit and cash.
Questions
What is Harmony Biosciences Holdings' free cash flow?
Harmony Biosciences Holdings' free cash flow was $126M in Q4 2025 (fourth quarter 2025), +16% from Q3 2025.
How has Harmony Biosciences Holdings' free cash flow changed?
Over the last 4 quarters it ranged from $33.9M (Q1 2025) to $126M (Q4 2025).
Q4 2025 results → · How Harmony Biosciences Holdings makes money →